← Eichor
Condition: Nephrotic Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nephrotic Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Phase N/A · 5 location(s) · University of Michigan · NCT01016613Non-invasive Diagnosis of Idiopathic Nephrotic Syndromes
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06820866An Outcome Analysis of Primary Membranous Nephropathy
Phase N/A · 2 location(s) · Mario Negri Institute for Pharmacological Research · NCT06242327Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07010250NEPTUNE Match Study
NA · 16 location(s) · University of Michigan · NCT04571658Steroid Diabetes in Patients With Kidney Disease
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT06161701Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06669949ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Phase N/A · 1 location(s) · Christoph Aufricht · NCT06162546A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Sev
Phase 2 · 1 location(s) · SynAct Pharma Aps · NCT04456816Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Phase N/A · 1 location(s) · University of Michigan · NCT05505500CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom
Phase N/A · 1 location(s) · Kolding Sygehus · NCT06373913Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
Phase 3 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT05734794Multitarget Strategy for Primary Podocytopathies
NA · 2 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06718894Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome
Phase 3 · 18 location(s) · Shoichi Maruyama MD PhD · NCT05914155Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syn
Phase 2/Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05786768A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidne
NA · 2 location(s) · St. James's Hospital, Ireland · NCT07561957Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children
Phase N/A · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06530004A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequen
Phase 2 · 1 location(s) · Mao Jianhua · NCT07087314The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Phase N/A · 12 location(s) · Prof. Dr. Paul Brinkkoetter · NCT03949972Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospe
Phase 3 · 8 location(s) · Mao Jianhua · NCT06079788Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2 · 47 location(s) · Travere Therapeutics, Inc. · NCT05003986A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
Phase N/A · 48 location(s) · University Hospital, Limoges · NCT04207580Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06792799The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome
NA · 1 location(s) · Ain Shams University · NCT07206537Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07507201INSIGHT (Insight Into Nephrotic Syndrome)
Phase N/A · 4 location(s) · The Hospital for Sick Children · NCT01605266Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
Phase N/A · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT06334692Blinatumomab for CNI-Resistant/Intolerant SRNS in Children
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06607991
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.